Breast cancer remains a leading cause of cancer-related death in women despite screening
and therapeutic advances. Early detection allows for resection of local disease; however …

Breast cancer is the most common cancer among women in the United States and the
second leading cause of cancer-related deaths; approximately 12.9% of women will be …

Breast cancer is the malignant tumor with the highest incidence in women worldwide. It is
highly heterogeneous, has a high incidence of drug resistance, recurrence, and metastasis …

Background: Machine learning (ML) approaches facilitate risk prediction model
development using high-dimensional predictors and higher-order interactions at the cost of …

Purpose Follow-up for breast cancer survivors consists of after care and surveillance. The
benefits of routine surveillance visits remain debatable. In this study we compared the …

Currently, more than 3.5 million breast cancer survivors live in the United States. 1 With 5-
year survival for local-regional cancer exceeding 90%, 1 that number will continue to grow …

Circulating tumor DNA in breast cancer: a biomarker for pati... : Current Opinion in Oncology
Circulating tumor DNA in breast cancer: a biomarker for patient selection : Current Opinion in …

Background An international retrospective cohort study was conducted to clarify the survival
advantage of combination therapy with locoregional and systemic therapy (ST) in …

Purpose Follow-up care of early breast cancer (EBC) patients usually includes routinely
scheduled physical examinations. While ASCO guidelines recommend a physical exam …

After patients complete multimodal treatment for breast cancer, they are usually followed
with frequent routinely scheduled in-person visits with physical examination for many years …